TRIM22 has also been shown to regulate MAPK signaling in GBM by mediating K48-linked ubiquitination and degradation of Raf-1 and the transcriptional regulation of sphingosine kinase 2 (SPHK2), thereby promoting GBM proliferation39. This evidence concerns the gene SPHK2 and glioblastoma.